Autologous CAR-T Cell Manufacturing: Current Standing and Future Directions
A Look at What Drug Manufacturers are Likely Using to Make CAR-T Products
Supplement: MilliporeSigma Sees Opportunity in Continuous Processing
From the GEN Sounds of Science Podcast
Why CAR-T Therapies Don’t Work for Everyone Yet
Selecting the Best Type of T Cells for CAR-T May be Key to the Overall Efficacy of the Therapies
Cell-Centered: Scientists Embrace Cell-Replacement Therapy for Type 1 Diabetes
Forming Beta Cells from Stem Cells
For full access to this article login to GEN Select now.
miRNA Becoming a Research Priority
New Pathways for Scientific Inquiries Are Being Revealed by a Multitude of Labs
- Since they were first discovered in 1993, miRNAs have created a great deal of excitement. These small pieces of RNA, only 21–22 nucleotides long, have emerged as potentially important regulators of cellular developmental pathways, proliferation, apoptosis, and differentiation. They represent the latest addendum to the central dogma of molecular ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.